ArticleScientific reports2025
Evaluation of a DNA methylation-based measure of chronic inflammation in two generations of adults in metropolitan Cebu, Philippines.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Why Does DNA Methylation Accumulate at CpG Loci?: Sequential Analysis ofActa histochemica et cytochemica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Proxy measures of chronic inflammation derived from DNA methylation (DNAm) data have emerged as promising predictors of cardiometabolic disease in high income countries. The performance of these measures in lower and middle income settings experiencing higher levels of endemic infections as well as rising rates of chronic degenerative diseases is not known. A DNAm-based proxy for C-reactive protein (DNAm-CRP) was calculated from 1468 CpG sites on the Infinium MethylationEPIC v1.0 array applied to genomic DNA from leukocytes in young adults (N = 1665; 20-22 years) and older women (N = 1070; 35-68 years) in the Philippines. CRP was determined in plasma using a high sensitivity immunoturbidimetric assay. Pearson correlation and least squares regression were implemented to evaluate the strength of association between DNAm-CRP and plasma CRP, and to investigate patterns of association between DNAm-CRP and established predictors of chronic inflammation. For younger adults, the correlation between DNAm-CRP and log-transformed CRP was 0.41, and DNAm-CRP explained 17.2% of the variance in CRP. For older women, the correlation was 0.47, with 22.7% explained variance in CRP. For both cohorts larger waist circumference was associated with higher DNAm-CRP. Recent infectious symptoms and leukocyte composition were both significant predictors of DNAm-CRP. DNAm-CRP may be a useful tool for research on chronic inflammation across a range of epidemiological and ecological settings globally, but future applications should consider how recent infections and the distribution of leukocyte subsets may confound or mediate associations of interest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.